Gene · 9656
Papers2,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LOXL2 reduces susceptibility to PARP inhibitors by promoting super-enhancer-regulated DNA damage repair in high-grade serous ovarian cancer. | Oncogene | 2025 | 40447755 | PubTator, text mining | PubMed |
| Circulating tumor DNA predicts clinical benefits of immune checkpoint blockade in HER2-negative patients with advanced gastric cancer. | Gastric Cancer | 2025 | 40372586 | PubTator, text mining | PubMed |
| Inherited deficiency of DIAPH1 identifies a DNA double strand break repair pathway regulated by γ-actin. | Nat Commun | 2025 | 40368919 | PubTator, text mining | PubMed |
| Performance of microbial desalination cells with different cathode types in treating saline wastewater. | Sci Rep | 2025 | 40346188 | PubTator, text mining | PubMed |
| Increased Number of Circulating Myeloid Dendritic Cell 1 in Patients with Severe Aplastic Anemia. | Clin Lab | 2025 | 40209793 | PubTator, text mining | PubMed |
| Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma. | Sci Adv | 2025 | 40203113 | PubTator, text mining | PubMed |
| MDC1 mediates Pellino recruitment to sites of DNA double-strand breaks. | Life Sci Alliance | 2025 | 40049731 | PubTator, text mining | PubMed |
| The relationship between telomere length and aging-related diseases. | Clin Exp Med | 2025 | 40044947 | PubTator, text mining | PubMed |
| Recent Advances in Anti-Aging Therapeutic Strategies Targeting DNA Damage Response and Senescence-Associated Secretory Phenotype-Linked Signaling Cascade. | Cell Biochem Funct | 2025 | 40008426 | PubTator, text mining | PubMed |
| Positive Selection Shapes Breast Cancer Tumor Suppressor Genes: Unveiling Insights into BRCA1, BRCA2, and MDC1 Stability. | J Mol Evol | 2025 | 39681652 | PubTator, text mining | PubMed |
| Co-regulator activity of Mediator of DNA Damage Checkpoint 1 (MDC1) is associated with DNA repair dysfunction and PARP inhibitor sensitivity in lobular carcinoma of the breast. | bioRxiv | 2025 | 39677775 | PubTator, text mining | PubMed |
| A novel protein encoded by circARHGAP12 attenuates DNA damage and apoptosis by regulating MDC1 in intestinal ischemia/reperfusion injury. | Int J Biol Macromol | 2025 | 39643171 | PubTator, text mining | PubMed |
| METTL16 is Required for Meiotic Sex Chromosome Inactivation and DSB Formation and Recombination during Male Meiosis. | Adv Sci (Weinh) | 2025 | 39607422 | PubTator, text mining | PubMed |
| DNA-damage dependent isoform switching modulates RIF1 DNA repair complex assembly and phase separation. | bioRxiv | 2025 | 39553946 | PubTator, text mining | PubMed |
| Traffic light at DSB-transit regulation between gene transcription and DNA repair. | FEBS Lett | 2025 | 39333024 | PubTator, text mining | PubMed |
| Phospho-Proteomics Analysis of Early Response to X-Ray Irradiation Reveals Molecular Mechanism Potentially Related to U251 Cell Radioresistance. | Proteomes | 2024 | 39846632 | PubTator, text mining | PubMed |
| Interaction of DDB1 with NBS1 in a DNA Damage Checkpoint Pathway. | Int J Mol Sci | 2024 | 39684807 | PubTator, text mining | PubMed |
| Phosphorylation of 'SDT-like' motifs in ATRX mediates its interaction with the MRN complex and is important for ALT pathway suppression. | Open Biol | 2024 | 39657822 | PubTator, text mining | PubMed |
| The ataxia-telangiectasia disease protein ATM controls vesicular protein secretion via CHGA and microtubule dynamics via CRMP5. | Neurobiol Dis | 2024 | 39615799 | PubTator, text mining | PubMed |
| The role of SUMOylation in biomolecular condensate dynamics and protein localization. | Cell Insight | 2024 | 39399482 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9656/papers?page=3